All In Biotech

Drug Trial Radar · NCT02563106

A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTI

A Double-Blind, Placebo-Controlled, Multicenter Study of SYN-004 Compared to Placebo for the Prevention of C.Diff in Patients With a Diagnosis of a Lower Respiratory Tract Infection

Last checked: Nov 19, 2026Latest source record: Nov 27, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 413 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

413

Actual

Start

Oct 2015

Primary completion

Nov 2016

Study completion Nov 2016

Sponsor

Lead sponsor
Theriva Biologics, Inc.Industry
Sponsor type
Industry
First posted
Sep 29, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
Who can join
All sexes, from 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 2b Parallel-Group, Double-Blind, Placebo-Controlled, Multicenter Study of SYN-004 Compared to Placebo for the Prevention of Clostridium difficile Infection (CDI) in Hospitalized Patients receiving IV ceftriaxone with a Diagnosis of a Lower Respiratory Tract Infection (LRTI).

Conditions

  • Clostridium Difficile
  • Clostridium Infections

Interventions

  • SYN-004Drug

  • PlaceboDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Patients With Clostridium Difficile Infection at 4- Weeks of Follow-up.Time frame: Day 1 to the 4 week Follow-up Visit.

Locations

43 sites in 7 countries. Site status is shown where the registry gives one.

  • Synthetic Biologics Investigational Site

    Little Rock, Arkansas

  • Synthetic Biologics Investigational Site

    Torrance, California

  • Synthetic Biologics Investigational Site

    DeLand, Florida

  • Synthetic Biologics Investigational Site

    Będzin, Louisiana

  • Synthetic Biologics Investigational Site

    Debrecen, Louisiana

  • Synthetic Biologics Investigational SIte

    Natchitoches, Louisiana

  • Synthetic Biologics Investigational Site

    Gabrovo, Bulgaria

  • Synthetic Biologics Investigational Site

    Kyustendil, Bulgaria

  • Synthetic Biologics Investigational Site

    Lovech, Bulgaria

  • Synthetic Biologics Investigational Site

    Multiple Locations, Bulgaria

  • Synthetic Biologics Investigational Site

    Rousse, Bulgaria

  • Synthetic Biologics Investigational Site

    Sevlievo, Bulgaria

  • Synthetic Biologics Investigational Site

    Sofia, Bulgaria

  • Synthetic Biologics Investigational Site

    Targovishte, Bulgaria

  • Synthetic Biologics Investigational Site

    Sherbrooke, Canada

  • Synthetic Biologics Investigational Site

    Toronto, Canada

  • Synthetic Biologics Investigational Site

    Balassagyarmat, Hungary

  • Synthetic Biologics Investigational Site

    Budapest, Hungary

  • Synthetic Biologics Investigational Site

    Veszprém, Hungary

  • Synthetic Biologics Investigational Site

    Bialystok, Poland

  • Synthetic Biologics Investigational Site

    Bochnia, Poland

  • Synthetic Biologics Investigational Site

    Bydgoszcz, Poland

  • Synthetic Biologics Investigational Site

    Chodzież, Poland

  • Synthetic Biologics Investigational Site

    Lodz, Poland

  • Synthetic Biologics Investigational Site

    Oława, Poland

  • Synthetic Biologics Investigational Site

    Pomorskie, Poland

  • Synthetic Biologics Investigational Site

    Siedlce, Poland

  • Synthetic Biologics Investigational Site

    Tarnów, Poland

  • SyntheticBiologics Investigational Site

    Tychy, Poland

  • Synthetic Biologics Investigational Site

    Warszawice, Poland

  • Synthetic Biologics Investigational Site

    Arad, Romania

  • Synthetic Biologics Investigational Site

    Brasov, Romania

  • Synthetic Biologics Investigational SIte

    Bucharest, Romania

  • Synthetic Biologics Investigational Site

    Cluj-Napoca, Romania

  • Synthetic Biologics Investigational Site

    Oradea, Romania

  • Synthetic Biologics Investigational Site

    Otopeni, Romania

  • Synthetic Biologics Investigational Site

    Timișoara, Romania

  • Synthetic Biologics Investigational Site

    Belgrade, Serbia

  • Synthetic Biologics Investigational Site

    Čačak, Serbia

  • Synthetic Biologics Investigational Site

    Gornji Matejevac, Serbia

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.